SCHEMBL24590076

SCHEMBL24590076

CCN(CC)c1ccc2c(C)c(CCOC(=O)NCCc3ccccc3)c(=O)oc2c1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGLV6-57 P01721 10/20 0.85
▸ MAPT P10636 4/20 0.57
▸ KDM4E B2RXH2 4/20 0.57
▸ ALDH1A1 P00352 4/20 0.57
▸ GLA P06280 3/20 0.57
▸ ATM Q13315 3/20 0.57
▸ HTT P42858 3/20 0.57
▸ THRB P10828 2/20 0.57
▸ CASP1 P29466 2/20 0.57
▸ CASP7 P55210 2/20 0.57
▸ HSD17B10 Q99714 2/20 0.57
▸ LMNA P02545 1/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ GAA P10253 2/20 0.55
▸ KLK7 P49862 1/20 0.55
▸ SRC P12931 2/20 0.51
▸ TDP1 Q9NUW8 1/20 0.49
▸ TP53 P04637 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24589899 0.95 IGLV6-57 (0.82) IGLV6-57MAPTKDM4EALDH1A1GLA
SCHEMBL24590000 0.92 IGLV6-57 (1.00) IGLV6-57MAPTKDM4EALDH1A1GLA
SCHEMBL24589806 0.91 IGLV6-57 (0.82) IGLV6-57MAPTKDM4EALDH1A1GLA
SCHEMBL24589888 0.90 IGLV6-57 (1.00) IGLV6-57MAPTKDM4EALDH1A1GLA
SCHEMBL29694187 0.87 IGLV6-57 (0.73) IGLV6-57MAPTKDM4EALDH1A1GLA
SCHEMBL24589617 0.87 IGLV6-57 (0.73) IGLV6-57MAPTKDM4EALDH1A1GLA
SCHEMBL22501693 0.86 MAPT (0.74) IGLV6-57MAPTKDM4EALDH1A1GLA
SCHEMBL24589921 0.86 IGLV6-57 (0.71) IGLV6-57MAPTKDM4EALDH1A1GLA
SCHEMBL22501772 0.85 IGLV6-57 (0.86) IGLV6-57MAPTKDM4EALDH1A1GLA
SCHEMBL24589337 0.85 IGLV6-57 (0.65) IGLV6-57MAPTKDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE 2022-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS TTR, MAP1LC3B, SAAL1 IGLV6-57 7/4885MAPT 41/4885KDM4E 4575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback